Determinants for asthma control, quality of life and use of complementary and alternative medicine in asthmatic pediatric patients in four cities

[1] Hon KL(2014)Clinical effectiveness and safety of montelukast in asthma. What are the conclusions from clinical trials and meta-analyses? Drug Des Devel Ther 8 839-850

[2] Leung TF(2005)Aligning patient care and asthma treatment guidelines Am J Manag Care 11 S416-S421

[3] Leung AK(2004)The global burden of asthma: executive summary of the GINA Dissemination Committee report Allergy 59 469-478

[4] Cannon E(2011)The genetics of asthma and allergic disease: a 21st century perspective Immunol Rev 242 10-30

[5] Masoli M(1998)Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Int Study Asthma Allergies Childhood (ISAAC) Steering Committee Lancet 351 1225-1232

[6] Fabian D(2011)Prevalence and risk factors of childhood allergic diseases in eight metropolitan cities in China: a multicenter study BMC Public Health 11 437-888

[7] Holt S(2006)Gender disparity in paediatric hospital admissions Ann Acad Med Singap 35 882-800

[8] Beasley R(2017)Asthma Lancet 391 783-483

[9] Ober C(2009)Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC) Thorax 64 476-697

[10] Yao TC(2011)Relationship between asthma control status, the Asthma Control Test and urgent health-care utilization in Asia Respirology 16 688-77

[1] Hon KL(2014)Clinical effectiveness and safety of montelukast in asthma. What are the conclusions from clinical trials and meta-analyses? Drug Des Devel Ther 8 839-850

[2] Leung TF(2005)Aligning patient care and asthma treatment guidelines Am J Manag Care 11 S416-S421

[3] Leung AK(2004)The global burden of asthma: executive summary of the GINA Dissemination Committee report Allergy 59 469-478

[4] Cannon E(2011)The genetics of asthma and allergic disease: a 21st century perspective Immunol Rev 242 10-30

[5] Masoli M(1998)Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Int Study Asthma Allergies Childhood (ISAAC) Steering Committee Lancet 351 1225-1232

[6] Fabian D(2011)Prevalence and risk factors of childhood allergic diseases in eight metropolitan cities in China: a multicenter study BMC Public Health 11 437-888

[7] Holt S(2006)Gender disparity in paediatric hospital admissions Ann Acad Med Singap 35 882-800

[8] Beasley R(2017)Asthma Lancet 391 783-483

[9] Ober C(2009)Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC) Thorax 64 476-697

[10] Yao TC(2011)Relationship between asthma control status, the Asthma Control Test and urgent health-care utilization in Asia Respirology 16 688-77